LONDON, Aug 11- GlaxoSmithKline faces new allegations that it bribed Syrian doctors and officials to boost sales of its medicines, following recent accusations of corruption in its non-prescription business in the country.» Read More
CNBC's Michelle Caruso-Cabrera and Scott Cohn provide the latest details on Wal-Mart's efforts to make a bribery case go away and the crackdown on foreign corruption. Also, a look inside Wal-Mart's culture, with CNBC's David Faber.
Jacob Frenkel, former SEC enforcement attorney, discusses the consequences Wal-Mart could face following allegations it tried to cover up a bribery investigation in Mexico.
CNBC's Courtney Reagan reports the latest details and fallout from an alleged bribery scandal in Mexico that hit Wal-Mart years ago.
A look at the U.S. markets ahead of the open, including an alleged bribery scandal involving Wal-Mart and its Mexican stores, and Pfizer selling its infant nutrition business to Nestles for $11.9B, with CNBC's Jackie DeAngelis.
Did Wal-Mart's Mexican division orchestrate a campaign of bribery to grab market dominance? Jeffrey Sonnenfeld, Yale School of Management weighs in on the investigation.
CNBC's Maria Bartiromo discusses investment opportunities in Russia, with Stephen Schwarzman, Blackstone chairman/CEO.
Dozens of foreign companies with London listings may be exempt from new anti-corruption laws, Ken Clarke has confirmed, a disclosure that will anger investors keen to preserve the integrity of London’s markets, the Financial Times reports.